A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Status: Recruiting
Location: See location...
Intervention Type: Drug, Radiation
Study Type: Observational
SUMMARY
The purpose of this study is to assess efficacy and safety of patients who receive Adebrelimab combined with chemotherapy±chest radiotherapy as first-line treatment of extensive stage small cell lung cancer in the real world.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Age:≥18 years old;
• Patients with extensive stage small cell lung cancer confirmed by histopathology;
• Normal function of major organs;
• Participants were willing to join in this study, and written informed consent, good adherence, cooperate with the follow-up.
Locations
Other Locations
China
Jun Wang
RECRUITING
Shijiazhuang
Time Frame
Start Date: 2024-03-26
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 50
Treatments
Experimental
Related Therapeutic Areas
Sponsors
Leads: Hebei Medical University Fourth Hospital